Clinical Trials Directory

Trials / Suspended

SuspendedNCT03914079

Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease

Status
Suspended
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
AusculSciences Canada Inc. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this multi-center study is to collect and study the acoustic and electrical signals created by the heart during the cardiac cycle as a result of stenosis or plaque associated with coronary artery disease (CAD).

Detailed description

This research intends to evaluate acoustic and electrical cardiovascular signals in patients with known or suspected CAD and establish the ability of the CAD-det System to accurately and reliably detect them utilizing coronary computed tomography (CCTA) and invasive coronary angiography (ICA) as reference standards. In addition, this study will collect clinical and acoustic data of other cardiac pathologies to better understand their impact on the acoustic signatures associated with CAD.

Conditions

Timeline

Start date
2019-04-05
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-04-16
Last updated
2021-01-12

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT03914079. Inclusion in this directory is not an endorsement.